2AA6.B | NR3C2

General Structure Information 2aa6 NR3C2 mineralocorticoid receptor s810l mutant with bound progesterone 1.95Å AUTH R.K.BLEDSOE,K.P.MADAUSS,J.A.HOLT,C.J.APOLITO,AUTH 2 M.H.LAMBERT,K.H.PEARCE,T.B.STANLEY,E.L.STEWART,AUTH 3 R.P.TRUMP,T.M.WILLSON,S.P.WILLIAMSTITL A LIGAND-MEDIATED HYDROGEN BOND NETWORK REQUIREDTITL 2 FOR THE ACTIVATION OF THE MINERALOCORTICOIDTITL 3 RECEPTORREF J.BIOL.CHEM. V. 280 31283 2005REFN ISSN 0021-9258PMID 15967794DOI 10.1074/JBC.M504098200 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Mapped Variants

See Details
2X0B.D | AGT

General Structure Information 2x0b AGT crystal structure of human angiotensinogen complexed with renin 4.33Å AUTH A.ZHOU,R.W.CARRELL,M.P.MURPHY,Z.WEI,Y.YAN,P.L.STANLEY,AUTH 2 P.E.STEIN,F.B.PIPKIN,R.J.READTITL A REDOX SWITCH IN ANGIOTENSINOGEN MODULATES ANGIOTENSINTITL 2 RELEASE.REF NATURE V. 468 108 2010REFN ISSN 0028-0836PMID 20927107DOI 10.1038/NATURE09505 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants

See Details
2VWI.C | OXSR1

General Structure Information 2vwi OXSR1 structure of the osr1 kinase, a hypertension drug target 2.15Å AUTH F.VILLA,M.DEAK,D.R.ALESSI,D.M.F.VAN AALTENTITL STRUCTURE OF THE OSR1 KINASE, A HYPERTENSION DRUG TARGET.REF PROTEINS V. 73 1082 2008REFN ISSN 0887-3585PMID 18831043DOI 10.1002/PROT.22238 Variant Set Distributions Mapped Variants

See Details